M3 Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

M3 wird ein jährliches Gewinn- und Umsatzwachstum von 12.1% bzw. 11.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 11.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13.5% betragen.

Wichtige Informationen

12.1%

Wachstumsrate der Gewinne

11.7%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum	16.6%
Wachstumsrate der Einnahmen	11.1%
Zukünftige Eigenkapitalrendite	13.5%
Analystenabdeckung	Good
Zuletzt aktualisiert	11 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Miss: M3, Inc. Missed EPS By 36% And Analysts Are Revising Their Forecasts

Nov 01

Results: M3, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Jul 30

Recent updates

Earnings Miss: M3, Inc. Missed EPS By 36% And Analysts Are Revising Their Forecasts

Nov 01

Is M3, Inc. (TSE:2413) Potentially Undervalued?

Oct 21

M3, Inc. (TSE:2413) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Oct 06

Return Trends At M3 (TSE:2413) Aren't Appealing

Sep 23

Some M3, Inc. (TSE:2413) Shareholders Look For Exit As Shares Take 26% Pounding

Aug 10

Results: M3, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Jul 30

Gewinn- und Umsatzwachstumsprognosen

TSE:2413 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (JPY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	343,326	54,760	51,545	N/A	12
3/31/2026	315,020	49,351	48,599	N/A	13
3/31/2025	271,809	44,507	28,082	N/A	13
9/30/2024	247,907	39,159	N/A	N/A	N/A
6/30/2024	245,696	44,105	N/A	N/A	N/A
3/31/2024	238,883	45,271	50,729	58,310	N/A
12/31/2023	234,852	46,363	48,074	59,340	N/A
9/30/2023	233,997	48,374	48,074	58,719	N/A
6/30/2023	231,218	49,315	49,924	59,680	N/A
3/31/2023	230,818	49,028	49,536	57,113	N/A
12/31/2022	229,145	46,955	49,787	54,523	N/A
9/30/2022	223,128	47,117	54,609	58,728	N/A
6/30/2022	218,752	60,203	49,565	53,415	N/A
3/31/2022	208,159	63,845	48,891	52,108	N/A
12/31/2021	199,617	67,280	46,178	48,867	N/A
9/30/2021	191,823	63,900	44,517	46,894	N/A
6/30/2021	180,123	47,124	45,531	47,375	N/A
3/31/2021	169,198	37,822	44,638	46,627	N/A
12/31/2020	158,404	31,760	38,205	40,464	N/A
9/30/2020	144,450	26,520	31,617	34,196	N/A
6/30/2020	135,685	23,190	26,405	29,364	N/A
3/31/2020	130,973	21,635	23,949	26,789	N/A
12/31/2019	125,704	21,589	23,863	26,246	N/A
9/30/2019	121,329	20,887	17,971	19,995	N/A
6/30/2019	116,927	19,865	17,924	19,463	N/A
3/31/2019	113,059	19,577	16,404	17,749	N/A
12/31/2018	109,585	19,532	12,206	13,931	N/A
9/30/2018	104,897	19,796	14,624	16,717	N/A
6/30/2018	99,495	19,580	N/A	15,908	N/A
3/31/2018	94,471	19,684	N/A	15,913	N/A
12/31/2017	90,402	18,934	N/A	16,314	N/A
9/30/2017	86,118	17,830	N/A	17,543	N/A
6/30/2017	81,960	17,303	N/A	17,382	N/A
3/31/2017	78,143	16,004	N/A	16,555	N/A
12/31/2016	73,570	14,871	N/A	14,848	N/A
9/30/2016	69,009	13,526	N/A	14,631	N/A
6/30/2016	67,189	12,953	N/A	13,813	N/A
3/31/2016	64,660	12,508	N/A	12,136	N/A
12/31/2015	60,288	11,664	N/A	10,106	N/A
9/30/2015	57,241	10,874	N/A	9,879	N/A
6/30/2015	54,598	10,486	N/A	8,931	N/A
3/31/2015	51,346	9,759	N/A	9,316	N/A
12/31/2014	48,687	9,740	N/A	9,085	N/A
9/30/2014	44,767	9,236	N/A	9,205	N/A
6/30/2014	40,966	8,838	N/A	8,714	N/A
3/31/2014	36,887	8,318	N/A	8,647	N/A
12/31/2013	33,967	7,409	N/A	7,483	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 2413Das prognostizierte Gewinnwachstum (12.1% pro Jahr) liegt über der Sparquote (0.3%).

Ertrag vs. Markt: 2413Die Erträge des Unternehmens (12.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt JP (9.1% pro Jahr).

Hohe Wachstumserträge: 2413Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 2413Die Einnahmen des Unternehmens (11.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt JP (4.2% pro Jahr).

Hohe Wachstumseinnahmen: 2413Die Einnahmen des Unternehmens (11.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 2413Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13.5%).

M3 Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Miss: M3, Inc. Missed EPS By 36% And Analysts Are Revising Their Forecasts

Price target decreased by 7.2% to JP¥1,834

Price target decreased by 7.2% to JP¥2,028

Results: M3, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Price target decreased by 9.3% to JP¥2,215

Price target decreased by 7.4% to JP¥2,263

Recent updates

Investor sentiment deteriorates as stock falls 18%

Earnings Miss: M3, Inc. Missed EPS By 36% And Analysts Are Revising Their Forecasts

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Is M3, Inc. (TSE:2413) Potentially Undervalued?

Investor sentiment improves as stock rises 18%

M3, Inc. (TSE:2413) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Return Trends At M3 (TSE:2413) Aren't Appealing

Price target decreased by 7.2% to JP¥1,834

M3, Inc. to Report Q2, 2025 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Some M3, Inc. (TSE:2413) Shareholders Look For Exit As Shares Take 26% Pounding

Price target decreased by 7.2% to JP¥2,028

Investor sentiment deteriorates as stock falls 19%

Results: M3, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Estimating The Intrinsic Value Of M3, Inc. (TSE:2413)

Is M3 (TSE:2413) Using Too Much Debt?

Now 18% overvalued

Investor Optimism Abounds M3, Inc. (TSE:2413) But Growth Is Lacking

Price target decreased by 9.3% to JP¥2,215

Now 20% overvalued

New minor risk - Share price stability

M3, Inc. to Report Q1, 2025 Results on Jul 26, 2024

M3 (TSE:2413) Will Be Hoping To Turn Its Returns On Capital Around

Price target decreased by 7.4% to JP¥2,263

Full year 2024 earnings: EPS misses analyst expectations

M3, Inc., Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥21.00 per share

M3's (TSE:2413) Dividend Will Be Increased To ¥21.00

Dividend increased to JP¥21.00

M3, Inc. to Report Fiscal Year 2024 Results on Apr 26, 2024

Is M3, Inc. (TSE:2413) Worth JP¥2.1k Based On Its Intrinsic Value?

Now 21% overvalued

Price target decreased by 7.9% to JP¥2,762

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 16%

New minor risk - Share price stability

M3, Inc. to Report Q3, 2024 Results on Jan 31, 2024

Price target decreased by 8.7% to JP¥3,000

Price target decreased by 7.7% to JP¥3,158

M3, Inc. (TSE:2413) entered into a share tender agreement to acquire a 55% stake in Benefit One Inc. (TSE:2412) from Pasona Group Inc. (TSE:2168) and others for approximately ¥140 billion.

Price target decreased by 7.3% to JP¥3,241

Price target decreased by 7.1% to JP¥3,422

Second quarter 2024 earnings: EPS exceeds analyst expectations

M3, Inc. Provides Consolidated Earnings Guidance for the Full Fiscal Year Ending March 31, 2024

M3, Inc. to Report Q2, 2024 Results on Oct 27, 2023

M3, Inc. (TSE:2413) acquired Messly Limited.

M3, Inc. (TSE:2413) acquired frogwell corporation.

M3, Inc. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and the Full Year Ending March 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

M3, Inc. to Report Q1, 2024 Results on Jul 28, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of JP¥19.00 per share at 0.5% yield

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

M3, Inc. (TSE:2413) acquired Michael Allen Company.

M3, Inc. to Report Q3, 2023 Results on Feb 03, 2023

No independent directors

Second quarter 2023 earnings released: EPS: JP¥18.38 (vs JP¥36.86 in 2Q 2022)

M3, Inc. (TSE:2413) acquired Rinkai Medical Service.

M3, Inc. to Report Q2, 2023 Results on Nov 02, 2022

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: JP¥19.87 (vs JP¥23.23 in 1Q 2022)

Investor sentiment improved over the past week

M3, Inc. (TSE:2413) acquired Edoctores Soluciones.

M3, Inc. to Report Q1, 2023 Results on Jul 27, 2022

Price target decreased to JP¥5,358

Full year 2022 earnings: EPS misses analyst expectations

M3, Inc. Announces Dividend for the Year Ended March 31, 2022, Payable on June 13, 2022

No independent directors